Publication | Closed Access

Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride

PathologyFatty Liver DiseaseObesityMetabolic SyndromeBody CompositionMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseFibroblast Growth FactorHepatology FibrosisHealth SciencesMetabolic Associated SteatohepatitisFibrosisLiver PhysiologyHepatology InflammationHepatic TriglycerideHepatologyLiver DiseaseLiverMedicine